Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2986 AL 3000

Promising Opportunities for Treating Neurodegenerative Diseases with Mesenchymal Stem Cell-Derived Exosomes

Guy R, Offen D.

Biomolecules. 2020 Sep 15;10(9):1320. doi: 10.3390/biom10091320.

Designing virtual communities of practice for informal caregivers of Alzheimer's patients: An integrative review

Romero-Mas M, Gómez-Zúñiga B, Cox AM, Ramon-Aribau A.

Health Informatics J. 2020 Dec;26(4):2976-2991. doi: 10.1177/1460458220950883. Epub 2020 Sep 19.

Exploring the regulatory roles of circular RNAs in Alzheimer's disease

Zhang Y, Zhao Y, Liu Y, Wang M, Yu W, Zhang L.

Transl Neurodegener. 2020 Sep 21;9(1):35. doi: 10.1186/s40035-020-00216-z.

Multifunctional nano-enabled delivery systems in Alzheimer's disease management

Qian C , Yuan C , Li C , Liu H , Wang X .

Biomater Sci. 2020 Oct 21;8(20):5538-5554. doi: 10.1039/d0bm00756k. Epub 2020 Sep 21.

Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease

Yi P, Zhang Z, Huang S, Huang J, Peng W, Yang J.

Pharm Biol. 2020 Dec;58(1):932-943. doi: 10.1080/13880209.2020.1817103.

The efficacy and safety of hachimijiogan for mild Alzheimer disease in an exploratory, open standard treatment controlled, randomized allocation, multicenter trial: A study protocol

Kainuma M, Funakoshi K, Ouma S, Yamashita KI, Ohara T, Yoshiiwa A, Murata M, Tsuboi Y.

Medicine (Baltimore). 2020 Sep 18;99(38):e22370. doi: 10.1097/MD.0000000000022370.

Short and medium-term effects of a multicomponent physical exercise program with a Mediterranean diet on bone mineral density, gait, balance, and fall risk for patients with Alzheimer disease: Randomized controlled clinical trial study protocol

Puente-González AS, Sánchez-González F, Hernández-Xumet JE, Sánchez-Sánchez MC, Barbero-Iglesias FJ, Méndez-Sánchez R.

Medicine (Baltimore). 2020 Sep 18;99(38):e22385. doi: 10.1097/MD.0000000000022385.

The Dual GLP-1/GIP Receptor Agonist DA4-JC Shows Superior Protective Properties Compared to the GLP-1 Analogue Liraglutide in the APP/PS1 Mouse Model of Alzheimer's Disease

Maskery M, Goulding EM, Gengler S, Melchiorsen JU, Rosenkilde MM, Hölscher C.

Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317520953041. doi: 10.1177/1533317520953041.

Tubulin modifying enzymes as target for the treatment of tau-related diseases

Rogowski K, Hached K, Crozet C, van der Laan S.

Pharmacol Ther. 2021 Feb;218:107681. doi: 10.1016/j.pharmthera.2020.107681. Epub 2020 Sep 19.

Heat therapy: possible benefits for cognitive function and the aging brain

Von Schulze AT, Deng F, Morris JK, Geiger PC.

J Appl Physiol (1985). 2020 Dec 1;129(6):1468-1476. doi: 10.1152/japplphysiol.00168.2020. Epub 2020 Sep 24.

A dyadic approach for a remote physical activity intervention in adults with Alzheimer's disease and their caregivers: Rationale and design for an 18-month randomized trial

Ptomey LT, Szabo-Reed AN, Vidoni ED, Washburn RA, Gorczyca AM, Little TD, Lee J, Helsel BC, Williams KN, Donnelly JE.

Contemp Clin Trials. 2020 Nov;98:106158. doi: 10.1016/j.cct.2020.106158. Epub 2020 Sep 23.

One call makes a difference: An evaluation of the Alzheimer's Association National Helpline on dementia caregiver outcomes

Hodgson NA, Petrovsky DV, Finegan K, Kallmyer BA, Pike J, Fazio S.

Patient Educ Couns. 2021 Apr;104(4):896-902. doi: 10.1016/j.pec.2020.09.026. Epub 2020 Sep 23.

Translating genetic risk of Alzheimer's disease into mechanistic insight and drug targets

Sierksma A, Escott-Price V, De Strooper B.

Science. 2020 Oct 2;370(6512):61-66. doi: 10.1126/science.abb8575.

Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020)

Rombouts F, Kusakabe KI, Hsiao CC, Gijsen HJM.

Expert Opin Ther Pat. 2021 Jan;31(1):25-52. doi: 10.1080/13543776.2021.1832463. Epub 2020 Dec 17.

Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease

Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta F.

Neuropharmacology. 2021 Jun 1;190:108352. doi: 10.1016/j.neuropharm.2020.108352. Epub 2020 Oct 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias